CME/CE

Jointly provided by The Postgraduate Institute for Medicine and DKBmed, LLC. 

Acknowledgement

This activity is supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc. 

Target Audience

The intended audience for these clinician webcasts is gastroenterologists and primary care providers (MDs/DOs, PAs, NPs, and RNs) in New Orleans and nationwide. 

Educational Objectives

Upon completion of this activity, participants should be able to: 

  • Describe the consequences of delayed IBD diagnosis. ​
  • Summarize tools and evaluations that are used to stratify risk and assess patients with IBD. ​
  • Assess evidence from trials that evaluated various treatment strategies. ​
  • Assess the efficacy and safety of currently available therapies for IBD. ​
  • Discuss strategies to improve management of SBS. 
  • Identify diagnostic criteria for eosinophilic esophagitis. ​
  • Describe best practices for monitoring patients with EoE. ​
  • Discuss the benefits and limitations of medications used to treat EoE. 

Disclosure of Financial Relationships

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity: 

Bharati Kochar, MD, MS, FACG  Consultant: Pfizer, Janssen Pharmaceuticals, Takeda Pharmaceuticals U.S.A. Inc., Merck & Co., Inc.
The PIM planners and other have nothing to disclose. The DKBmed planners and others have nothing to disclose.

IBD/SBS Webcast

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine (PIM) and DKBmed LLC. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PIM designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.25 contact hours. 

PA Continuing Medical Education

PIM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until xxx. PAs should only claim credit commensurate with the extent of their participation.


EoE Webcast

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine (PIM) and DKBmed LLC. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PIM designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours. 

PA Continuing Medical Education

PIM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until xxx. PAs should only claim credit commensurate with the extent of their participation.


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

There are no fees for participating and receiving CME/CE credit for this activity. 

Request for Credit (IBD/SBS Webcast)

If you wish to receive acknowledgment for completing this activity, please complete the evaluation. 

  • Release date: July 15, 2026 
  • Expiration date: July 14, 2027 

Estimated time to complete the activity: 1 hour 15 minutes 

Request for Credit (EoE Webcast)

If you wish to receive acknowledgment for completing this activity, please complete the evaluation. 

  • Release date: July 15, 2026 
  • Expiration date: July 14, 2027 

Estimated time to complete the activity: 75 minutes 

Hardware & Software Requirements

To access activities, users will need:

  • A computer with an internet connection
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher) 

Contact Information

For additional information about the accreditation of this activity, please email [email protected]